Management of the Heart Failure Patient with Functional Mitral Regurgitation

Agenda

• Moderator Introduction: Amar Krishnaswamy, MD
• Case Presentation: Vanessa Blumer, MD
• Implications of Functional MR and Optimizing GDMT: Mangeet Chahal, MD
• TEE Imaging to Understand the Anatomic Features of FMR: Rhonda Miyasaka, MD
• CT Imaging to Guide Catheter-based MV Replacement: Serge Harb, MD
• Percutaneous MV Repair – Options and Results : Amar Krishnaswamy, MD
• Percutaneous MV Replacement – Options and Results: Samir Kapadia, MD
• Presenter Panel Discussion

Learning Objectives:

• Describe contemporary procedures to treat patients with functional mitral regurgitation.
• Discuss novel therapies and management options in mitigating the adverse impact of FMR.
• Recognize considerations and outcomes for percutaneous MV repair and replacement.

Complete CME process to claim your credit

Target Audience

This online series is designed for physicians, allied health practitioners and students interested in complex cardiovascular and thoracic conditions.

Accreditation Statement

In support of improving patient care, Cleveland Clinic Center for Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation American Medical Association (AMA)
Cleveland Clinic Center for Continuing Education designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

Certificate of Participation
A certificate of participation will be provided to other health care professionals for requesting credits in accordance with their professional boards and/or associations.

CME Disclaimer

The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic. In no event will The Cleveland Clinic be liable for any decision made or action taken in reliance upon the information provided through this CME activity.

Faculty Disclosure

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are Free of commercial bias.

The following faculty has indicated they have no relationship which, in the context of their presentation(s), could be perceived as a potential conflict of interest: Jeanna Sigmund, MSN, Rhonda Miyasaka, MD, Amar Krishnaswamy, MD, Mangeet Chahal, MD, Vanessa Blumer, MD, Kathleen Breznai.

The following faculty has indicated that they may have a relationship, which in the context of their presentation(s) could be perceived as a potential conflict of interest: Eric E Roselli, MD, Activity Director: Cook Medical - Teaching and Speaking. Artivion - Consulting. Terumo - Teaching and Speaking. W.L. Gore & Associates - Consulting. Medtronic - Consulting. Edwards Lifesciences - Teaching and Speaking. Abbott - Teaching and Speaking. LivaNova, PLC - Consulting, Teaching and Speaking. Serge Harb, MD: Centerline Biomedical - Ownership interest (stock, stock options in a publicly owned company). Mitria - CCF spin off company - Consulting. Watchman Truplan CT software - Consulting, Advisor or review panel participant. Abbott - Consulting. Samir Kapadia, MD: Navigate - Ownership interest (stock, stock options in a publicly owned company).